百诚医药
(301096)
| 流通市值：36.28亿 | | | 总市值：47.68亿 |
| 流通股本：8311.46万 | | | 总股本：1.09亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 304,442,101.61 | 160,457,682.24 | 677,987,094.68 | 509,883,681.59 |
| 营业总成本 | 316,103,695.05 | 151,266,524.68 | 748,339,939.83 | 508,846,004.57 |
| 其他经营收益 | | | | |
| 营业利润 | 752,293.69 | 12,196,917.65 | -89,034,649.17 | 7,650,161.61 |
| 利润总额 | 724,447.06 | 12,247,472.65 | -91,138,964.38 | 7,965,059.06 |
| 净利润 | 1,593,651.56 | 12,812,458.42 | -90,395,530.08 | 6,124,209.96 |
| 每股收益 | | | | |
| 其他综合收益 | 8,967.08 | 11,144 | -40,484.38 | -42,606.52 |
| 综合收益总额 | 1,602,618.64 | 12,823,602.42 | -90,436,014.46 | 6,081,603.44 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,663,271,455.71 | 1,698,414,001.24 | 1,552,083,379.64 | 1,818,269,330.28 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,087,236,102.44 | 2,103,967,906.05 | 2,134,184,239.54 | 2,128,658,111.86 |
| 资产总计 | 3,750,507,558.15 | 3,802,381,907.29 | 3,686,267,619.18 | 3,946,927,442.14 |
| 流动负债: | | | | |
| 流动负债合计 | 901,671,153.81 | 906,457,407.83 | 919,912,108.28 | 1,030,000,641.09 |
| 非流动负债: | | | | |
| 非流动负债合计 | 355,080,015.88 | 394,147,127.22 | 277,401,741.08 | 331,455,413.33 |
| 负债合计 | 1,256,751,169.69 | 1,300,604,535.05 | 1,197,313,849.36 | 1,361,456,054.42 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,492,320,584.6 | 2,501,777,372.24 | 2,488,953,769.82 | 2,585,471,387.72 |
| 股东权益合计 | 2,493,756,388.46 | 2,501,777,372.24 | 2,488,953,769.82 | 2,585,471,387.72 |
| 负债和股东权益合计 | 3,750,507,558.15 | 3,802,381,907.29 | 3,686,267,619.18 | 3,946,927,442.14 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 254,081,553.02 | 118,415,232.6 | 434,556,414.02 | 253,832,979.49 |
| 经营活动现金流出小计 | 258,968,312.8 | 125,266,312.66 | 589,201,103.91 | 433,618,596.71 |
| 经营活动产生的现金流量净额 | -4,886,759.78 | -6,851,080.06 | -154,644,689.89 | -179,785,617.22 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 35,358,083.51 | 31,706,160.43 | 418,505,415.52 | 308,533,773.48 |
| 投资活动现金流出小计 | 74,024,926.83 | 50,573,746.85 | 539,310,775.12 | 497,016,464.8 |
| 投资活动产生的现金流量净额 | -38,666,843.32 | -18,867,586.42 | -120,805,359.6 | -188,482,691.32 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 460,000,000 | 290,411,113.1 | 1,061,282,342.62 | 816,782,342.6 |
| 筹资活动现金流出小计 | 368,972,536.64 | 158,195,038.48 | 921,438,959.66 | 507,875,522.38 |
| 筹资活动产生的现金流量净额 | 91,027,463.36 | 132,216,074.62 | 139,843,382.96 | 308,906,820.22 |
| 汇率变动对现金及现金等价物的影响 | -9,887.73 | -2,550.9 | -78,180.21 | 312,756.01 |
| 现金及现金等价物净增加额 | 47,463,972.53 | 106,494,857.24 | -135,684,846.74 | -59,048,732.31 |
| 期末现金及现金等价物余额 | 327,940,471.85 | 386,971,356.56 | 280,476,499.32 | 357,112,613.75 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 47,463,972.53 | - | -135,684,846.74 | - |
最新报告期：2026-08-31| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东吴证券 | 苏丰,朱国广 | 0.68 | 1.57 | 1.91 | 2026-08-31 |